ClinicalTrials.Veeva

Menu

Delirium in Covid-19: Germany-wide Covid-19 Intensive Register

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

Post Intensive Care Unit Syndrome
Covid19
Intensive Care Unit Delirium

Study type

Observational

Funder types

Other

Identifiers

NCT04775017
COVID-19-Delirium

Details and patient eligibility

About

The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.

Enrollment

2,398 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients with SARS-CoV-2 positive Covid-19 disease

  • Age≥18 years
  • Proven by positive PCR tests from nasal/ throat swabs as well as samples from the deep respiratory tract.
  • Period 01.01.2020 to 21.02.2022

Exclusion criteria

  • NONE

Trial contacts and locations

1

Loading...

Central trial contact

Claudia Spies, MD, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems